healthcare.digital January 16, 2026
Strategic Roadmap for European HealthTech and MedTech Shareholder Value in 2026
The European healthcare technology and medical technology (MedTech) landscape entering 2026 stands at a profound inflection point, characterised by a transition from the speculative fragmentation of the early 2020s to a disciplined era of “Industrial Maturity”. The macroeconomic environment has shifted decisively from the “growth at all costs” paradigm that defined the Zero Interest Rate Policy (ZIRP) era to a rigorous focus on “profitable efficiency,” unit economics and regulatory fortitude. This is not merely a cyclical adjustment; it is a structural transformation of the asset class.
For founders and boards operating in this space, 2026 is not simply another fiscal year; it is a “clearing event” driven by Regulatory...
Today's Sponsors
Today's Sponsor